Cargando…
Azathioprine Has a Deleterious Effect on the Bone Health of Mice with DSS-Induced Inflammatory Bowel Disease
Patients with inflammatory bowel disease (IBD) often present poor bone health and are 40% more at risk of bone fracture. Studies have implicated autophagy in IBD pathology and drugs used to treat IBD stimulate autophagy in varying degrees, however, their effect on the skeleton is currently unknown....
Autores principales: | Morgan, Stephanie, Hooper, Kirsty M., Milne, Elspeth M., Farquharson, Colin, Stevens, Craig, Staines, Katherine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929096/ https://www.ncbi.nlm.nih.gov/pubmed/31816823 http://dx.doi.org/10.3390/ijms20236085 |
Ejemplares similares
-
Suppressor of cytokine signaling 2 (Socs2) deletion protects bone health of mice with DSS-induced inflammatory bowel disease
por: Dobie, Ross, et al.
Publicado: (2018) -
Tenascin-C is a driver of inflammation in the DSS model of colitis
por: Ozanne, James, et al.
Publicado: (2022) -
Increased PHOSPHO1 expression mediates cortical bone mineral density in renal osteodystrophy
por: Hsu, Shun-Neng, et al.
Publicado: (2022) -
How To Build a Bone: PHOSPHO1, Biomineralization, and Beyond
por: Dillon, Scott, et al.
Publicado: (2019) -
Proton Pump Inhibitors Inhibit PHOSPHO1 Activity and Matrix Mineralisation In Vitro
por: Staines, Katherine A., et al.
Publicado: (2021)